SCHEMBL19620987

SCHEMBL19620987

Cc1cc(C2CC2)[nH]c(=O)c1CNC=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
YTHDF2 Q9Y5A9 2/20 0.36
YTHDF3 Q7Z739 1/20 0.36
YTHDF1 Q9BYJ9 1/20 0.36
EZH2 Q15910 10/20 0.34
RAPGEF4 Q8WZA2 2/20 0.34
EED O75530 5/20 0.33
RBBP4 Q09028 5/20 0.33
SUZ12 Q15022 5/20 0.33
AEBP2 Q6ZN18 3/20 0.33
RBBP7 Q16576 2/20 0.33
DAO P14920 1/20 0.33
EZH1 Q92800 1/20 0.32
NR3C1 P04150 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20334459 0.79 EZH2 (0.43) KDM4EEZH2EEDRBBP4SUZ12
SCHEMBL1694607 0.77 YTHDF2 (0.41) KDM4EALDH1A1GLAPOLBGAA
Hydrochloric Acid SCHEMBL1694726 0.76 YTHDF2 (0.40) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL17970490 0.74 EZH2 (0.35) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL9887551 0.73 EZH2 (0.45) GAAEZH2EEDRBBP4SUZ12
SCHEMBL14727105 0.73 DAO (0.39) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL2587816 0.72 DAO (0.38) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL1694956 0.71 KDM4E (0.61) KDM4EALDH1A1GLAPOLBGAA
Hydrochloric Acid SCHEMBL2595212 0.71 DAO (0.37) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL5543692 0.70 ADH1B (0.39) ALDH1A1HSD17B10RAPGEF4TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246027-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF CANCER GlaxoSmithKline LLC (US) 2017-11-22 EP disclosed